Literature DB >> 16214456

Ventricular remodeling in children with left ventricular dysfunction secondary to various cardiomyopathies.

Lloyd Y Tani1, L LuAnn Minich, Richard V Williams, Robert E Shaddy.   

Abstract

The ventricular remodeling that occurs in adults with left ventricular (LV) dysfunction is characterized by a change in LV shape from an ellipse to more of a sphere and is associated with increased functional mitral regurgitation (MR), decreased exercise tolerance, and poor outcome. There are limited data on the occurrence and importance of LV remodeling in children with LV dysfunction. The purposes of this study were to evaluate in children with LV dysfunction (1) LV shape, (2) changes in LV shape as LV function improves, and (3) the relation between LV shape and functional MR. Children with LV dysfunction were identified and compared with controls. Patient demographics, treatment, and outcomes were noted. Echocardiograms were reviewed for LV function and shape (sphericity index). The echos of a subset of children whose LV ejection fractions (LVEFs) increased by >10% over a follow-up of >6 months were analyzed for changes in sphericity, mitral annulus size, and the degree of MR. Twenty-five children with LV dysfunction were compared with 37 age-matched controls. LV remodeling to a more spherical shape was inversely related to LVEF but was not associated with clinical outcome. In a subset of patients (n = 17) whose LVEFs improved, the reversal of remodeling (decrease in sphericity index) was associated with a decrease in MR and mitral annulus size. In conclusion, LV remodeling occurs in children with LV dysfunction. The reversal of this remodeling with a decrease in the degree of MR and the size of the mitral annulus occurs as systolic function improves.

Entities:  

Mesh:

Year:  2005        PMID: 16214456     DOI: 10.1016/j.amjcard.2005.06.047

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Echocardiographic evaluation of children with systemic ventricular dysfunction treated with carvedilol.

Authors:  Colin Petko; L LuAnn Minich; Melanie D Everitt; Richard Holubkov; Robert E Shaddy; Lloyd Y Tani
Journal:  Pediatr Cardiol       Date:  2010-08       Impact factor: 1.655

Review 2.  Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy.

Authors:  Rita Wen Kaspar; Hugh D Allen; Federica Montanaro
Journal:  J Am Acad Nurse Pract       Date:  2009-05

3.  Experimental models of duchenne muscular dystrophy: relationship with cardiovascular disease.

Authors:  Venus Ameen; Lesley G Robson
Journal:  Open Cardiovasc Med J       Date:  2010-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.